olpadronic acid has been researched along with Brittle Bone Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Engelbert, R; Jansen, M; Kok, D; Pruijs, H; Sakkers, R; Schweitzer, D; Uiterwaal, C; van Dongen, A; Verbout, A | 1 |
Castelein, RM; Engelbert, RH; Janse, AJ; Kok, DH; Pruijs, HE; Sakkers, RJ; Verbout, AJ | 1 |
Landsmeer-Beker, EA; Maaswinkel-Mooy, PD; Massa, GG; Papapoulos, SE; van de Kamp, JJ | 1 |
2 trial(s) available for olpadronic acid and Brittle Bone Disease
Article | Year |
---|---|
Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study.
Topics: Activities of Daily Living; Administration, Oral; Adolescent; Bone Density; Bone Resorption; Child; Child, Preschool; Diphosphonates; Double-Blind Method; Female; Fractures, Spontaneous; Humans; Locomotion; Male; Osteogenesis Imperfecta | 2004 |
Quality of life in children with osteogenesis imperfecta treated with oral bisphosphonates (Olpadronate): a 2-year randomized placebo-controlled trial.
Topics: Achievement; Administration, Oral; Child; Diphosphonates; Double-Blind Method; Humans; Osteogenesis Imperfecta; Psychometrics; Quality of Life; Self Concept; Severity of Illness Index; Sociometric Techniques; Surveys and Questionnaires | 2007 |
1 other study(ies) available for olpadronic acid and Brittle Bone Disease
Article | Year |
---|---|
Treatment of osteogenesis imperfecta with the bisphosphonate olpadronate (dimethylaminohydroxypropylidene bisphosphonate).
Topics: Body Height; Bone Density; Child; Diphosphonates; Follow-Up Studies; Humans; Infant; Long-Term Care; Male; Osteogenesis Imperfecta | 1997 |